Age related macular degeneration (AMD) is a progressive condition that requires consistent monitoring, but the setting for that care depends on the severity and type of the disease. In the United Kingdom, many people with dry AMD are managed effectively within primary care by high street optometrists rather than in a hospital setting. Dry AMD involves a slow, gradual thinning of the macula, and for many, this process does not require the intensive medical interventions, such as injections, that are mandatory for the “wet” form of the disease. However, as the condition reaches advanced stages or if there is a risk of it transitioning to wet AMD, the role of the hospital eye clinic becomes more significant. Understanding the UK clinical pathway helps patients ensure they are receiving the right level of care at the right time.
What We’ll Discuss in This Article
- The primary role of high street opticians in managing stable dry AMD.
- When a dry AMD patient might be referred to a hospital specialist.
- The clinical markers that trigger a move from primary to secondary care.
- How advanced dry AMD (geographic atrophy) is monitored in the UK.
- The importance of the “fast track” system for sudden visual changes.
- Long term support and low vision services provided by the NHS.
The role of the high street optometrist in dry AMD
For most people diagnosed with early or intermediate dry AMD, the high street optometrist is the lead clinician for their care. In the UK, optometrists have the specialist equipment, such as Optical Coherence Tomography (OCT) scanners and digital retinal cameras, to monitor the macula for changes in drusen size and retinal thickness. Because dry AMD typically progresses very slowly over many years, these routine checks are usually scheduled every 12 to 24 months.
Managing dry AMD in a community setting is the preferred model in the UK because it is more accessible for patients and reduces the pressure on busy hospital eye departments. During these appointments, the optometrist will provide essential lifestyle advice, such as smoking cessation and nutritional guidance, which are the primary ways to slow the disease. As long as the dry AMD remains stable and does not cause a sudden drop in vision, hospital check-ups are generally not required. You can find more information on how opticians monitor dry AMD through the NHS.
When hospital referrals become necessary
A patient with dry AMD will be referred to a hospital eye clinic if the optometrist detects specific changes that require a consultant’s opinion or specialized treatment. The most common reason for an urgent hospital referral is the suspected transition from dry to wet AMD. If the optometrist sees signs of new fluid, bleeding, or if the patient reports sudden visual distortion (wavy lines), they will initiate a fast-track referral to ensure the patient is seen by a specialist within two weeks.
Hospital referrals may also be made for “late stage” dry AMD, known as geographic atrophy. While there is currently no standard injection treatment for the dry form in the UK, a hospital consultant may be involved to confirm the diagnosis, rule out other conditions, or assess the patient for clinical trials of new therapies. Furthermore, if the vision loss has reached a point where the patient is eligible for certification as sight impaired, a hospital consultant must perform the formal assessment. Detailed standards on referral criteria are provided by NICE.
Monitoring advanced dry AMD (Geographic Atrophy)
Geographic atrophy is the advanced form of dry AMD where patches of the macula have permanently wasted away. While this does not involve leaking blood vessels, the vision loss can be significant. In some parts of the UK, patients with geographic atrophy may be monitored in “virtual clinics” run by hospitals. In these clinics, a technician takes the necessary scans and photos, which are then reviewed later by an ophthalmologist.
The purpose of monitoring geographic atrophy is to track the “atrophic” patches and monitor the risk of the condition developing a “wet” component, which can still happen even in advanced dry cases. It also ensures the patient is referred to low vision services at the appropriate time. Organisations like SarcoidosisUK and other specialist groups often highlight how multi system monitoring is vital for rare or complex inflammatory presentations, though for standard AMD, the focus remains strictly ocular.
Care Settings for Dry AMD Management
| Stage of Dry AMD | Typical Care Setting | Frequency of Monitoring |
| Early | High Street Optician | Every 12 to 24 months |
| Intermediate | High Street Optician | Every 6 to 12 months |
| Advanced (GA) | Optician or Hospital | Every 6 to 12 months |
| Suspected “Wet” | Urgent Hospital Clinic | Immediate / within 2 weeks |
| Low Vision Needs | Low Vision Clinic (Hospital) | As required for aids |
The importance of self-monitoring between appointments
Because people with dry AMD are not seen in a hospital every few weeks, self-monitoring is a critical part of their care plan. The UK healthcare system relies on patients being aware of their “baseline” vision and reporting any sudden changes immediately. The most effective tool for this is the Amsler grid, which allows patients to check for the wavy lines that signal a transition to wet AMD.
If a patient with dry AMD notices a sudden change, they should not wait for their next scheduled hospital or optician appointment. Instead, they should contact their local optometrist for an urgent review. This proactive approach ensures that the “dry” label is still accurate and that no new, treatable “wet” activity has started. This partnership between the patient and primary care is the most effective way to manage dry AMD without unnecessary hospital visits.
Conclusion
Most people with dry AMD do not need regular hospital check-ups and are safely managed by high street optometrists. Hospital care is typically reserved for those who develop the “wet” form of the disease, those with very advanced geographic atrophy, or those requiring formal sight impairment certification. By attending regular community eye tests and monitoring your vision at home with an Amsler grid, you can ensure that you receive specialist hospital care only when it is clinically necessary. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can I ask for a hospital referral for my dry AMD?
Your optometrist will refer you if there is a clinical need, such as a rapid decline in vision or if the diagnosis is uncertain; otherwise, community care is the standard.
What happens at a hospital appointment for dry AMD?
The specialist will perform advanced scans like OCT and autofluorescence to measure the health of the retinal layers and discuss any available support or trials.
Is dry AMD less serious than wet AMD?
While dry AMD progresses more slowly, its advanced stages can still lead to significant vision loss, so all forms should be taken seriously and monitored.
Why does the NHS manage dry AMD in opticians?
High street opticians have the same diagnostic equipment as many hospitals, making it more efficient and convenient for patients with stable conditions.
Can dry AMD turn into wet AMD at any time?
Yes, approximately 10% to 15% of people with dry AMD will develop the wet form, which is why monitoring for sudden changes is so important.
Do I have to pay for my optician checks if I have AMD?
In the UK, if you are over 60 or have been diagnosed with a complex eye condition, you are usually entitled to free NHS eye examinations.
Are there any new hospital treatments for dry AMD?
There are new treatments for geographic atrophy being researched and gradually introduced in the UK, but these are currently reserved for specific advanced cases.
Authority Snapshot
This article clarifies the clinical pathways for dry AMD management in the United Kingdom. It was prepared by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a UK trained physician with experience in internal medicine and emergency care. The content is strictly aligned with the clinical standards and referral protocols established by the NHS and the National Institute for Health and Care Excellence (NICE) for the management of chronic eye conditions.



